See the Brighton Collaboration standarized templates:
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
Template for the Evaluation of Vaccines for Maternal Immunization
See the completed standarized templates:
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
